Novel Hip Implant

Total hip arthroplasty is a common solution for osteoarthritis, yet many patients face revision surgeries due to aseptic loosening. To address this challenge, the project introduces an innovative hip implant that incorporates a drug-eluting mechanism—releasing growth factors like BMP-2—to enhance bone integration and joint stability. The design leverages advanced computational tools for stress analysis and drug diffusion simulation, ensuring the implant adheres to critical durability, safety, and biocompatibility standards.

Additionally, extensive market research and stakeholder analysis were conducted to tailor the implant for North American patients aged 45 to 64. By integrating controlled drug release into the implant structure and optimizing design parameters through iterative prototyping and simulation, this novel system aims to reduce the incidence of revision surgeries and improve long-term outcomes for patients undergoing total hip arthroplasty.

Below is a report and presentation of our design.